Your browser doesn't support javascript.
loading
[The initial value evaluation of ¹8F-fluorodeoxyglucose positron emission tomography in the diagnosis of chest malignant tumors].
Tian, Feng; Han, Yong; Zhao, Zhengyuan; Yang, Ye; Chen, Lianhong; Cheng, Qingshu.
Afiliación
  • Tian F; Department of Thoracic Surgery, Tangdu Hospital, Xi'an, Shaanxi 710038, P.R.China.
Zhongguo Fei Ai Za Zhi ; 10(4): 310-2, 2007 Aug 20.
Article en Zh | MEDLINE | ID: mdl-21122300
ABSTRACT

BACKGROUND:

¹8F-fluorodeoxyglucose positron emission tomography (¹8F-FDG PET) is considered as one of the most valuable diagnostic methods of chest malignant tumors, except for pathological diagnosis. But in clinic, the cases whose diagnosis of ¹8F-FDG PET is different from pathological diagnosis are not rare. This study is to evaluate the initial value of ¹8F-FDG PET in the diagnosis and staging of the chest malignant tumors.

METHODS:

Fifty-one cases of chest tumors in Xi'an who underwent ¹8F-FDG PET were collected. Additionally, pathologic diagnosis had also been experienced on the patients through operation, percutaneous puncture, bronchoscopy or film preparation of pleural fluid. By the comparison of ¹8F-FDG PET diagnosis and the pathologic diagnosis, accuracy, sensitivity, specificity, false positive rate, positive predictive and negative predictive of ¹8F-FDG PET were calculated.

RESULTS:

In 51 patients, there were 34 patients whose ¹8F-FDG PET diagnoses were consistent with the pathological diagnoses, including 31 true positive, 3 true negative. Out of another 17 patients, 11 were false positive, including 2 sarcoidosis, 6 tuberculosis of the lung, 2 inflammatory pseudotumor of the lung and 1 pulmonary cryptococcosis, and 6 were false negative. The calculated values were 66.67% on the overall accuracy, 83.78% on sensitivity, 21.43% on specificity, 78.57% on false positive rate, 16.21% on false negative rate, 73.81% on positive predictive value and 33.33% on negative predictive value.

CONCLUSIONS:

Currently, ¹8F-FDG PET is still one of the most advanced unwounded technologies for the chest malignant tumor diagnosis. However, this technology experiences difficulties in detection of some high metabolized benign disease, such as tuberculosis from malignant tumor. Hence, in order to take advantage of ¹8F-FDG PET technology and have more accurate diagnosis of chest tumors, both results from the ¹8F-FDG PET and the clinic actuality should be considered.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: Zh Revista: Zhongguo Fei Ai Za Zhi Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: Zh Revista: Zhongguo Fei Ai Za Zhi Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article
...